RADAR on Specialty Pharmacy

Study: ‘Drug Super Spender’ Members Doubled in Four Years

The United States is seeing a surge of innovative specialty therapeutics coming onto the market, many of which offer potential treatments for conditions that previously didn’t have one. But many of these newer the...
0 Comments

Cancer-Related Services Drop, Could Have Long-Lasting Impact

Years of advances in driving down cancer occurrences and deaths could be completely reversed by the COVID-19 pandemic. A recently published study shows screenings, diagnoses and treatment for various cancers dropped...
0 Comments

Survey: Oncologists Expect To Prescribe Onureg in AML

With the FDA’s approval last month of Onureg (azacitidine), people with acute myeloid leukemia (AML) now have an oral version of a longtime injectable treatment within that class. Zitter Insights found that more t...
0 Comments

HOSP Forms to Advocate for Integrated Specialty Pharmacies

As the specialty pharmacy industry continues to grow, more entities within the health care system are boosting their capabilities in this area, and various health systems are implementing some form of a specialty ph...
0 Comments

Prime Launches Medical Benefit Management Tool MedSelect

While a variety of strategies are available to manage specialty drugs in the pharmacy benefit, that’s not traditionally been the case with drugs that fall under the medical benefit. Prime Therapeutics LLC is addin...
0 Comments

New FDA Specialty Approvals

✦ Oct. 7: The FDA expanded the label of BioMarin Pharmaceutical Inc.’s Palynziq (pegvaliase-pqpz) to increase the maximum allowable dose to 60 mg for the treatment of adults with phenylketonuria. The agency init...
0 Comments

News Briefs

✦ CMS is delaying the start of the Radiation Oncology Model from Jan. 1, 2021, to July 1, 2021. The move comes after CMS announced the launch date on Sept. 18, and multiple entities, including the American Society...
0 Comments

Administration Ramps Up Drug Pricing Focus on Medicare B, D

The administration continued its push to reduce drug spending with a Sept. 13 executive order focused on Medicare Part B and Part D. While previous efforts had focused on Part B, including an International Pricing I...
0 Comments

Law Will Allow Calif. to Produce, Distribute Biosimilars, Generics

As the focus on drug prices continues (see story above), California recently took a step that it hopes will “increase patient access to affordable drugs,” according to a bill recently signed by the governor. But...
0 Comments

AllianceRx Walgreens Prime Launches Digital Clinical Tools

As the COVID-19 pandemic wears on, it’s more important than ever for people to have the ability to perform needed actions from home. To help with this, AllianceRx Walgreens Prime has released some digital clinical...
0 Comments